BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19857300)

  • 21. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero.
    Mittendorf R
    Teratology; 1995 Jun; 51(6):435-45. PubMed ID: 7502243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
    DeMars LR; Van Le L; Huang I; Fowler WC
    Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
    Hanselaar AG; Boss EA; Massuger LF; Bernheim JL
    Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up study of male and female offspring of DES-treated mothers a preliminary report.
    Bibbo M; Al-Naqeeb M; Baccarini I; Gill W; Newton M; Sleeper KM; Sonek RN; Wied GL
    J Reprod Med; 1975 Jul; 15(1):29-32. PubMed ID: 1171234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
    Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
    Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Med Assoc State Ala; 1977 Mar; 46(9):39-41. PubMed ID: 845523
    [No Abstract]   [Full Text] [Related]  

  • 34. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A young woman with clear cell adenocarcinoma of the uterine cervix.
    Seki H; Takada T; Sodemoto T; Hoshino H; Saitoh K; Uekusa T
    Int J Clin Oncol; 2003 Dec; 8(6):399-404. PubMed ID: 14663645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.
    Smith EK; White MC; Weir HK; Peipins LA; Thompson TD
    Cancer Causes Control; 2012 Jan; 23(1):207-11. PubMed ID: 22015647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
    Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of cervicovaginal abnormalities in DES-exposed women. A comparison of changes in sexually inactive women and the effects of the onset of sexual activity.
    Frank AR; Krumholz BA; Deutsch S
    J Reprod Med; 1985 May; 30(5):400-3. PubMed ID: 4009562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.